Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm Freenome ...

Freenome, a biotechnology company pioneering an early cancer detection platform, today announced an exclusive license agreement with Exact Sciences to advance the commercialization of its colorectal ...

During National Wellness Month, the American Red Cross encourages people to prioritize their personal health and well-being while helping to save lives with a blood or platelet donation. Donors of all ...

Exact Sciences bought the rights to Freenome's blood-based colon cancer test. The news could spark Exact Sciences stock.

Cryotherapy, infant stem cells, extreme cold, IV infusions, red light therapy, blue light therapy … more Australians are ...

A blood test being studied in Virginia could detect 10 different types of cancer with a single screening, potentially transforming early detection and treatment outcomes.

An Osaka Metropolitan University-led research team examined the medical records of 133 dogs that visited an emergency ...

Dietary fat is an important part of our diet. It provides us with a concentrated source of energy, transports vitamins and ...

A groundbreaking blood test being studied in Virginia could detect 10 different types of cancer with a single screening, ...

Raising awareness of medical products and services is a marathon, not a sprint, and Babson Diagnostics has therefore selected a star with plenty of stamina for a long-term partnership. | Raising ...

Respiratory disorders in dogs can quickly become critical and are reported to be the second leading cause of cardiac arrest ...

HealthDay News — Just under half of patients receiving an abnormal blood-based colorectal cancer screening test result receive a follow-up colonoscopy (FU-CY) within 6 months, according to a study ...